Home Overview Press Room Blog Publications For Students about us
Search

News Article

The Lessons of Asilomar for Today’s Scienceby Alexander CapronThe New York TimesMay 28th, 2015Four decades ago, concerns about the science of recombinant DNA led to a global moratorium on cutting-edge research.
$15 Million for Calimmune and California Stem Cell HIV Trialby David JensenCalifornia Stem Cell ReportMay 27th, 2015Calimmune, Inc., which has received $8.3 million from the California stem cell agency, announced it has rustled up another $15 million to help out with the work that the agency is backing.
Study Reveals Shortcomings in Gene Testing; Results on Estimating Disease Risk Often Conflictby Marilynn MarchioneAssociated PressMay 27th, 2015The first report from a big public-private project to improve genetic testing reveals it is not as rock solid as many people believe.
Academies Wrestle with Germline Editing[Quotes CGS's Marcy Darnovsky]by Alex PhilippidisGenetic Engineering & Biotechnology NewsMay 27th, 2015“We need many Asilomar-type meetings" and participants should include "both scholars and non-scholars — people from public interest organizations of different kinds, labor unions, community groups, and church groups."
Let’s Talk About the Ethics of Germline Modificationby Gregor WolbringImpact EthicsMay 27th, 2015We need clarity about where the public discussion should take place, what exactly it should focus on, and who should participate.
The University of Minnesota’s Medical Research Messby Carl ElliottThe New York TimesMay 26th, 2015Rather than dealing forthrightly with these ethical breaches, university officials have seemed more interested in covering up wrongdoing with a variety of underhanded tactics.
A Note on Genome Editingby John P. HoldrenOffice of Science and Technology PolicyMay 26th, 2015The Administration believes that altering the human germline for clinical purposes is a line that should not be crossed at this time.
Here’s a Greek Business That’s Booming: Making Test-Tube Babiesby Maria PetrakisBloombergMay 25th, 2015“There might be a financial crisis, but people will still pay to get a child when they want one.”
So You’re Related to Charlemagne? You and Every Other Living European…by Adam RutherfordThe GuardianMay 24th, 2015The advent of cheap genetic sequencing has given birth to a burgeoning ancestry industry. But before you pay to spit in a tube, let me give you a few facts for free.
Public Polling on Human Genetic Modification: Mixed, but Favor Moratoriumby Paul KnoepflerKnoepfler Lab Stem Cell BlogMay 23rd, 2015The results make a case for more inclusion of the public in the dialogue on the use of gene editing in humans.
Displaying 1-10 of 3766  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760